| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Program name | Description of program | Have we recommended one or more grants to support this program? | If we haven't recommended grants to support this program, why not? | Current status | ||||||||||||||||||||||
2 | Bridges to Prosperity | Building footbridges in rural areas in sub-Saharan Africa and Latin America to connect isolated households to schools, health clinics, and markets. (More) | Yes, we recommended a grant to Bridges to Prosperity in May 2022 (more). | - | Actively supporting | ||||||||||||||||||||||
3 | Chlorine vouchers | Offering vouchers for free redemption of household water chlorination treatment. (More) | Yes, we recommended grants to Development Innovation Lab in January 2023 (more) and January 2024 (more). | - | Actively supporting | ||||||||||||||||||||||
4 | Community-based management of acute malnutrition | Identifying and treating uncomplicated cases of both severe acute malnutrition and moderate acute malnutrition on an outpatient basis. (More) | Yes, we recommended grants to ALIMA in January 2021 (more), May 2021, and November 2022 (more), and to IRC in May through August 2021 (more), October 2021 (more), and January 2024 (more). | - | Actively supporting | ||||||||||||||||||||||
5 | Conditional cash transfers to increase infant vaccination as run by New Incentives | Providing cash transfers to caregivers who bring their infants to receive routine vaccinations, along with outreach to encourage vaccination and efforts to ensure vaccines are available in clinics. (More on the program; more on the evidence) | Yes, ongoing support to top charity New Incentives (more) | - | Actively supporting | ||||||||||||||||||||||
6 | Deworming (mass drug administration targeting schistosomiasis and/or soil-transmitted helminths) | Treating all school-aged children with anti-parasitic drugs in areas at risk for schistosomiasis and/or soil-transmitted helminths once or twice per year. (More) | Yes, ongoing support. We have made grants to Evidence Action's Deworm the World Initiative (more), Unlimit Health (more), Sightsavers' deworming program (more), and the END Fund's deworming program (more) | - | Actively supporting | ||||||||||||||||||||||
7 | Electronic immunization registry and mobile-based conditional cash transfers to increase vaccination as run by IRD Global | Providing conditional cash transfers using a mobile phone-based platform to incentivize infant immunization in seven high-risk/low-immunization districts in Sindh Province, Pakistan. (More) | Yes, we recommended grants to IRD Global in October 2021 (more) and February 2023 (more). | - | Actively supporting | ||||||||||||||||||||||
8 | Family planning radio campaigns | Conducting radio campaigns that aim to increase modern contraceptive use among women. | Yes, we made a grant to Family Empowerment Media in March 2023 (more). | - | Actively supporting | ||||||||||||||||||||||
9 | Intermittent preventive treatment in infants (IPTi) for malaria | Providing preventive antimalarial medicine to children aged 1-15 months at routine vaccination visits. (More) | Yes, we recommended a scoping grant to Malaria Consortium and PATH in 2021 (more) | - | Actively supporting | ||||||||||||||||||||||
10 | Iron fortification | Mass fortification of staple foods, such as wheat flour, to reduce iron deficiency. (More) | Yes, we recommended a grant to Fortify Health in 2018 (more), 2019 (more), and 2022 (more). We recognized Food Fortification Initiative (more) and Project Healthy Children (more) as GiveWell standout charities before GiveWell retired that designation. | - | Actively supporting | ||||||||||||||||||||||
11 | Iron supplementation for school-age children | Distributing iron supplements to school-age children to prevent anemia. (More) | Yes, we recommended grants to Evidence Action Beta (now called Evidence Action Accelerator) in December 2018 (more) and March 2018 (more), as well as grants to Evidence Action in 2022 (more) and 2024 (more) that included folic acid supplementation. | - | Actively supporting | ||||||||||||||||||||||
12 | Kangaroo mother care (KMC) | Providing a low-cost alternative to conventional neonatal intensive care for low birth weight infants during their stay at a healthcare facility. (More) | Yes, we made a grant to r.i.c.e. in 2022 (more). | - | Actively supporting | ||||||||||||||||||||||
13 | Malaria vaccine | Administration of the RTS,S malaria vaccine to young children in regions with moderate to high transmission as part of a comprehensive malaria control program. (More) | Yes, we recommended a grant to PATH in January 2022 (more). | - | Actively supporting | ||||||||||||||||||||||
14 | Mass distribution of long-lasting insecticide-treated nets | Giving long-lasting insecticide-treated nets (LLINs) to everyone in areas at risk of malaria, generally every three years. (More) | Yes, ongoing support to top charity Against Malaria Foundation (more). We also made a grant to Malaria Consortium in 2021 (more). | - | Actively supporting | ||||||||||||||||||||||
15 | One Acre Fund's tree program | Providing tree seedlings and training to small-scale farmers in sub-Saharan Africa. (More) | Yes, we recommended grants to One Acre Fund in September 2022 (more) and January 2023 (more). | - | Actively supporting | ||||||||||||||||||||||
16 | Oral Rehydration Solution (ORS) and zinc supplementation | Treating dehydration due to diarrhea with glucose, sodium, and other minerals dissolved in water, in addition to short-term zinc supplementation. (More) | Yes, we made a grant to the Clinton Health Access Initiative in September 2023 (more). | Actively supporting | |||||||||||||||||||||||
17 | Participatory Learning and Action - Maternal and Neonatal Health | Running facilitated meetings of groups of women of reproductive age, especially pregnant women, to develop localized strategies to increase appropriate care-seeking and improve uptake of prevention practices aiming to improve maternal and newborn health. (More) | Yes, we recommended grants to Spark Microgrants in 2022 (more) and University College London in 2023 (more). | - | Actively supporting | ||||||||||||||||||||||
18 | Ponseti casting for clubfoot | Treatment for clubfoot typically consisting of sequential casting to restore foot alignment, surgery on the Achilles tendon, and subsequent bracing to maintain alignment. (More) | Yes, we recommended grants to MiracleFeet in January 2023 (more) and May 2023 (more). | Actively supporting | |||||||||||||||||||||||
19 | Seasonal malaria chemoprevention | Giving children under the age of 5 courses of malaria treatment monthly during the annual period of highest malaria transmission. (More) | Yes, ongoing support to top charity Malaria Consortium (more) | - | Actively supporting | ||||||||||||||||||||||
20 | SMS reminders for immunization | Sending Short Message Service (SMS) messages to caregivers' cell phones to remind them of young children's upcoming vaccination dates. (More) | In April 2023 we recommended a grant to Suvita (more). We previous recommended grants to Charity Science Health (more). | Actively supporting | |||||||||||||||||||||||
21 | Syphilis screening and treatment during pregnancy | Providing rapid point-of-care testing and treatment of syphilis during pregnancy to prevent the complications of syphilis infection for the child and mother. (More) | Yes, we recommended grants to Evidence Action in 2020 (more) and 2022 (more). | - | Actively supporting | ||||||||||||||||||||||
22 | Vitamin A supplementation | Treating all children aged approximately 6-months to 5-years in areas at high-risk for vitamin A deficiency with high-dose vitamin A supplements two or three times per year. (More) | Yes, ongoing support to top charity Helen Keller International's Vitamin A supplementation program (more). We also made grants to Nutrition International in 2022 (more) and 2023 (more). | - | Actively supporting | ||||||||||||||||||||||
23 | Water quality interventions | Removing or disabling pathogens in water (through, for example, filtration or chlorination) in order to prevent waterborne disease, particularly diarrheal disease (More) | Yes, in January 2022 we made a grant of up to $64.7 million to Evidence Action's Dispensers for Safe Water (more), in July 2022 (more), July 2023 (more), and September 2023 (more) we made grants to Evidence Action's in-line chlorination program, and in October 2022 we made a grant to One Acre Fund to scope in-line chlorination opportunities (more). | Actively supporting | |||||||||||||||||||||||
24 | Breastfeeding promotion | Encouraging mothers to increase breastfeeding exclusivity and duration. (More) Alive & Thrive's program, for example, includes delivering a package of infant and young child feeding interventions focused on breastfeeding promotion and support, including face-to-face counseling, community mobilization, and mass media communications. (More) | No | This program appears promising, and we may investigate opportunities to potentially fund breastfeeding promotion in certain contexts. See our review of breastfeeding promotion and Alive & Thrive's program. | Further work planned | ||||||||||||||||||||||
25 | Cash transfers | Giving cash grants to poor people in low-income countries. (More) | We supported GiveDirectly from 2012-2022 (more). In July 2022, we we recommended a grant to researchers at the University of California, Berkeley to support a follow-up of a randomized controlled trial of GiveDirectly’s program in Kenya (more). | Waiting for new evidence | |||||||||||||||||||||||
26 | Chlorhexidine for umbilical cord care | Applying chlorhexidine, a widely-used topical antiseptic, to the newborn umbilical cord stump after birth to prevent infection and resulting neonatal death. (More) | No | This program appears promising in some circumstances and we plan to conduct additional research. See our review of this program. | Further work planned | ||||||||||||||||||||||
27 | Community-based intervention packages to reduce maternal and neonatal mortality | Providing various interventions to women during and after pregnancy and to newborns via community outreach workers, for example keeping newborns warm immediately after birth, promoting and assisting with breastfeeding, providing vitamin K to newborns, and referring sick infants to clinics. (More) | No | We've made grants to promising interventions to reduce maternal and neonatal mortality, such as kangaroo mother care (more) and PLA-MNH (more). We are still interested in identifying a promising community-based intervention package program. | Further work planned | ||||||||||||||||||||||
28 | Eyeglasses to improve workers' manual dexterity | Providing free or subsidized eyeglasses to workers whose productivity depends on their manual dexterity. (More) | No | Our review of this program found that the program may be within the range of cost-effectiveness of programs we would consider directing funding to. However, we have not yet found a funding opportunity that is within this range. | No further work planned | ||||||||||||||||||||||
29 | Facility-based maternal and neonatal health interventions | Providing training to health workers to deliver a package of maternal and neonatal health interventions in health facilities during and following birth, up to discharge. (More) | No | This program appears promising, and we are investigating funding opportunities. Because we are highly uncertain about the effectiveness of specific programs conducted by charities, we may consider including an evaluation of any program to which we recommend a grant. See our review of this program. | Further work planned | ||||||||||||||||||||||
30 | Mass distribution of azithromycin to reduce child mortality | Providing an antibiotic to all children in a certain age range once or twice per year. (More) | No | Our review of this program found that the program may be within the range of cost-effectiveness of programs we would consider directing funding to. We plan to do more work to understand whether there are implementation opportunities and whether these mitigate risks of antimicrobial resistance. | Research ongoing | ||||||||||||||||||||||
31 | Probiotic supplementation for preterm newborns | Providing probiotic supplements to low-birth-weight or preterm newborns to prevent necrotizing enterocolitis (NEC) and sepsis. (More) | No | This program appears promising. We plan to do more work to understand whether there are implementation opportunities. See our review of this program. | Further work planned | ||||||||||||||||||||||
32 | Sayana® Press | Providing an injectable contraceptive in a prefilled single-use package, intended to be easy for community health workers or recipients themselves to administer. (More) | No | This program appears promising, and we plan to conduct additional research. See our review of this program. | Further work planned | ||||||||||||||||||||||
33 | Attractive toxic sugar baits for malaria control | Reducing mosquito populations with mixtures of sugar and substances that are lethal to mosquitoes, in order to reduce malaria transmission. | No | We have deprioritized due to lack of evidence but expect new evidence to be available in the future. See our short note on this program. | Waiting for new evidence | ||||||||||||||||||||||
34 | Community health promoters as run by Living Goods | Selling health and household goods door-to-door and providing basic health counseling. (More) | This is not a program we are actively supporting. We recognized Living Goods as a GiveWell standout charity before GiveWell retired that designation (more). | We are aware of an ongoing randomized controlled trial that measures the effect of Living Goods’ program at a larger scale. We plan to revisit this program once the results from the larger-scale trial are available. See our review of this program. | Waiting for new evidence | ||||||||||||||||||||||
35 | Community salt substitution | Replacement of normal table salt with a salt substitute, in which potassium chloride replaces a portion of the sodium chloride, for all members of a community (More) | No | Our best guess is that community salt substitution is not as cost-effective as programs we would consider directing funding to. We plan to revisit when the findings of the Salt Substitute and Stroke Study are published. See our review of this program. | Research ongoing | ||||||||||||||||||||||
36 | Eave tubes to control malaria | Installing tubes with insecticide-treated netting into the space between the roof and walls of a house, to kill mosquitoes as they enter or exit. | No | We have deprioritized due to lack of evidence but expect new evidence to be available in the future. See our short note on this program. | Waiting for new evidence | ||||||||||||||||||||||
37 | Educate! Experience program | Mentoring students in their last two years of secondary school, with a focus on developing leadership, preparing to enter the workforce, and entrepreneurship skills. | No | We have deprioritized due to lack of evidence but expect new evidence to be available in the future. See our short note on this program. | Waiting for new evidence | ||||||||||||||||||||||
38 | Electronic partogram | Assisting health facilities to switch from paper-based to electronic partograms for tracking and managing care for women during labor. | No | We have deprioritized due to lack of evidence but expect new evidence to be available in the future. See our short note on this program | Waiting for new evidence | ||||||||||||||||||||||
39 | HPV vaccination to prevent cervical cancer | Providing HPV vaccinations to girls aged 9 to 14, in order to prevent cervical cancer. (More) | No | After a limited investigation, we believe there are probably not substantial funding gaps in HPV vaccination as of 2020. As of 2020, demand for HPV vaccine doses exceeds supply, and we believe it will take several years for industry to substantially increase production of HPV vaccines. See our review of this program. | Research ongoing | ||||||||||||||||||||||
40 | Vouchers for water treatment | Offering vouchers for free bottles of chlorine treatment to disinfect drinking water. (More) | Yes, we recommended a grant in January 2023 to the Development Innovation Lab to support a randomized controlled trial of vouchers for water chlorination (grant page forthcoming). | Reseach ongoing | |||||||||||||||||||||||
41 | Antenatal corticosteroids for pregnant women at risk of preterm birth | Administering antenatal corticosteroids to women between 24 weeks and 34 weeks of gestation who are at risk of preterm birth to reduce the risk of adverse newborn outcomes. | No | We have deprioritized further work on this program based on our uncertainty about the differing results reported by previous trials and our concern about the potential for harmful effects. See our short note on this program. We plan to revisit once evidence is available from an ongoing trial. | Waiting for new evidence | ||||||||||||||||||||||
42 | Antiretroviral therapy to treat HIV/AIDS | Treating people living with HIV with antiretroviral drugs on an ongoing basis to reduce illness and extend life. (More) | No | Our best guess is that this program is below the level of cost-effectiveness of programs that we would consider directing funding to. See our review of this program. | No further work planned | ||||||||||||||||||||||
43 | Artemisia tea | Treating malaria with a tea made from Artemisia plants. | No | We have deprioritized further work on this program based on our shallow assessment of the evidence of effectiveness for the program. See our short note on this program. | No further work planned | ||||||||||||||||||||||
44 | Aspirin for cardiovascular disease prevention | Providing aspirin to individuals at risk of cardiovascular disease in order to reduce the likelihood of cardiovascular events, such as heart attack and stroke. | No | We have deprioritized further work on this program based on our shallow assessment of the cost-effectiveness of the program and our impression that giving opportunities will be challenging to identify. See our short note on this program. | No further work planned | ||||||||||||||||||||||
45 | Bracelets for immunization | Providing infants with bracelets of different colors indicating immunization status as a strategy for increasing immunization rates through social signaling. | No | We have deprioritized further work on this program based on our shallow assessment of the cost-effectiveness of the program and evidence of its effectiveness in settings outside of Sierra Leone. See our short note on this program. | No further work planned | ||||||||||||||||||||||
46 | Bt eggplant adoption | Supporting farmers' adoption of Bt eggplants, which are genetically modified to be toxic to pests that can destroy the crop. | No | We have deprioritized further work on this program based on our shallow assessment of its cost-effectiveness and our impression that there is limited room for more funding. See our short note on this program. | No further work planned | ||||||||||||||||||||||
47 | Cataract surgery | Conducting surgery to remedy cataracts (clouding of the lens of the eye which prevents clear vision) involving removal of the eye's natural lens, followed by replacement with an artificial intraocular lens. (More) | No | Based on conversations with several cataract surgery charities, we have been unable to identify opportunities where there is compelling evidence that activities by charities lead to an increase in surgeries and think this information would be challenging to collect. See our review of this program. | No further work planned | ||||||||||||||||||||||
48 | Clean cookstoves | Providing or selling cookstoves that are designed to reduce indoor air pollution, relative to open fires fueled by biomass fuels such as firewood or dung. (More) | No | We have deprioritized further work on this program based on our assessment of the evidence of effectiveness for the program. See our review of this program. | No further work planned | ||||||||||||||||||||||
49 | Community distribution of polypill for cardiovascular disease prevention | Distribution of polypill, a pill containing fixed doses of several drugs intended to reduce the risk of cardiovascular disease. | No | We have deprioritized further work on this program based on our shallow assessment of the cost-effectiveness of the program. See our short note on this program. | No further work planned | ||||||||||||||||||||||
50 | Community-based antibiotic delivery for possible serious bacterial infection (PSBI) management | Providing home-based antibiotics to treat infections in neonates when hospital referrals aren't possible. | No | We have deprioritized further work on this program given the lack of evidence on community-based antibiotic delivery by itself. We may revisit if we identify more evidence available on the effects of PSBI management using community-based antibiotic delivery alone. See our short note on this program. | No further work planned | ||||||||||||||||||||||
51 | Conditional subsidies for seasonal labor migration in northern Bangladesh | Providing cash transfers or limited-liability interest-free loans to support seasonal labor migration in northern Bangladesh. (More) | This is not a program we are actively supporting. We supported Evidence Action's No Lean Season program in 2014-2019 (more). Subsequent evidence led to deprioritizing this program. | We have deprioritized further work on this program based on our assessment of the evidence of effectiveness of the program. Our review of this program mentions a 2018 randomized controlled trial. As of December 2020, to our knowledge, results from the 2018 RCT are not yet public. | No further work planned | ||||||||||||||||||||||
52 | Condom promotion and distribution to prevent HIV/AIDS | Encouraging the use of condoms through education, counseling and advertising. and/or providing condoms for free or at highly subsidized prices. (More) | No | We have deprioritized further work on this program based on our assessment of the evidence of effectiveness for the program. See our review of this program. | No further work planned | ||||||||||||||||||||||
53 | Cryptococcal antigen testing for people living with HIV | Diagnosing and treating a fungal infection that can cause death, particularly among people living with HIV. | No | We have deprioritized further work on this program based on our impression that there is a lack of cost-effective room for more funding. See our short note on this program. | No further work planned | ||||||||||||||||||||||
54 | Deworming pregnant people | Providing a single dose of prophylactic deworming for pregnant people to reduce worm infections, which contribute to anemia in women of reproductive age. | No | We have deprioritized further work on this program based on our impression that there will be limited funding opportunities. See our short note on this program. | No further work planned | ||||||||||||||||||||||
55 | Diagnosis and treatment for chronic pulmonary aspergillosis | Diagnosing and treating a fungal infection that can cause death, particularly among people who have underlying structural lung disease. | No | We have deprioritized further work on this program based on our impression that there is limited evidence of its effectiveness in low-resource settings and implementation is challenging in these settings. See our short note on this program. | No further work planned | ||||||||||||||||||||||
56 | Diagnosis and treatment for disseminated histoplasmosis | Diagnosing and treating a fungal infection that can cause death, particularly among people living with HIV. | No | We have deprioritized further work on this program based on our shallow assessment of the cost-effectiveness of the program and room for more funding. See our short note on this program. | No further work planned | ||||||||||||||||||||||
57 | Diagnosis and treatment for pneumocystis pneumonia | Diagnosing and treating a fungal infection that can cause death, particularly among people living with HIV. | No | We have deprioritized further work on this program based on our shallow assessment of the evidence of effectiveness and cost-effectiveness for the program. See our short note on this program. | No further work planned | ||||||||||||||||||||||
58 | Distribution of eyeglasses to improve academic performance | Providing free or subsidized corrective eyeglasses to students with poor vision to improve academic performance. (More) | No | We have deprioritized further work on this program based on our assessment of the evidence of effectiveness. We are prioritizing work on eyeglasses to improve workers' manual dexterity (listed separately) more highly because we believe that the evidence for effectiveness is stronger for that program. See our review of this program. | No further work planned | ||||||||||||||||||||||
59 | Early childhood psychosocial stimulation | Training parents to support their child's development through play and other activities, in order to develop children's cognitive and language skills. (More) | No | We have deprioritized further work on this program based on our assessment of evidence of effectiveness for and cost-effectiveness of the program. See our review of this program. | No further work planned | ||||||||||||||||||||||
60 | Education in developing countries | A wide range of interventions aimed at improving education in developing countries. (More) | No | We have deprioritized further work on these programs based on our assessment of the evidence of effectiveness for programs of this type. See our review of this category of programs. We may consider individual education interventions in the future. | No further work planned | ||||||||||||||||||||||
61 | Eggs for complementary feeding | Distributing chicken eggs to families to feed to infants in conjunction with breast milk to ensure that the infants receive adequate nutrition. | No | We have deprioritized further work on this program based on our shallow assessment of the cost-effectiveness of the program. See our short note on this program. | No further work planned | ||||||||||||||||||||||
62 | Generic hepatitis C medication | Providing generic versions of direct-acting antivirals to treat hepatitis C infections. | No | We have depriortized further work on this program based on our shallow assessment of the cost-effectiveness of the program. See our short note on this program. | No further work planned | ||||||||||||||||||||||
63 | Immunization to prevent meningitis A | Conducting meningitis A immunization campaigns, in order to prevent deaths and cases of brain damage and hearing loss. (More) | No | We have deprioritized further work on this program based on our assessment of room for more funding for the program. See our review of this program. | No further work planned | ||||||||||||||||||||||
64 | Integrated community case management | Training community health workers and providing them with the supplies to diagnose and treat uncomplicated cases of pneumonia with antibiotics, malaria with antimalarial drugs, and diarrhea with oral rehydration salts and zinc. (More) | No | We have deprioritized further work on this program based on our assessment of the evidence of effectiveness for the program. See our review of this program. | No further work planned | ||||||||||||||||||||||
65 | Intermittent preventive treatment of malaria during pregnancy | Providing antimalarial drugs to pregnant women who are at-risk of malaria in their second and third trimesters. (More) | No | Our review of this program found low cost-effectiveness and weak evidence of effectiveness for this program. | No further work planned | ||||||||||||||||||||||
66 | Interventions to promote handwashing | Promoting handwashing through education and/or provision of materials, such as soap. (More) | No | We have deprioritized further work on this program based on our assessment of evidence of effectiveness for and cost-effectiveness of the program. See our review of this program. | No further work planned | ||||||||||||||||||||||
67 | Lymphoedema management to prevent acute adenolymphangitis in podoconiosis | Educating people with podoconiosis about disease management practices and providing them with supplies, such as compression bandages and shoes, with the intention of reducing the incidence of acute adenolymphangitis. | No | We have deprioritized further work on this program based on our shallow assessment of the cost-effectiveness of the program. See our short note on this program. | No further work planned | ||||||||||||||||||||||
68 | Malaria rapid diagnostic tests (RDTs) | Use of malaria RDTs to reduce overprescription of antimalarials and improve diagnosis of non-malaria febrile illnesses. | No | We have deprioritized further work on this program due to lack of evidence that provision of malaria RDTs reduces mortality, which we guess would be necessary for this to meet our bar for cost-effectiveness. See our short note on this program. | No further work planned | ||||||||||||||||||||||
69 | Manual water pumps for farming households | Distributing manual water pumps to smallholder farmers to help irrigate crops during periods of low rainfall. | No | We have depriortized further work on this program based on our shallow assessment of its cost-effectiveness. See our short note on this program. | No further work planned | ||||||||||||||||||||||
70 | Mass media to promote behavior change as run by Development Media International | Encouraging people to adopt improved health practices though radio and television programming. (More) | This is not a program we are actively supporting. We made a grant to Development Media International in 2020 as part of our grantmaking in response to COVID-19 (more). We recognized Development Media International as a GiveWell standout charity before GiveWell retired that designation (more). | We view this program as having limited evidence of effectiveness, based on a randomized controlled trial of DMI's child mortality programs. See our review of this program. | No further work planned | ||||||||||||||||||||||
71 | Mass screen-and-treatment programs for tuberculosis | Testing all individuals over a certain age for tuberculosis and providing treatment for those with the disease. (More) | This is not a program we are actively supporting. We supported IRD's ZeroTB program with bridge grants in 2021, 2022 (more), and 2023 (more). | Our best guess is that mass screen-and-treatment programs for tuberculosis would be below the range of cost-effectiveness of programs we would direct funding to. However, we are uncertain about the feasibility of implementation and differences in costs and benefits across different geographies. It is possible that new, direct evidence could update us about whether mass screen-and-treatment for tuberculosis meets our cost-effectiveness bar. | No further work planned | ||||||||||||||||||||||
72 | Microfinance | Providing loans and other financial services (such as savings accounts or insurance) to poor individuals. (More) | This is not a program we are actively supporting. Small Enterprise Foundation was a GiveWell standout charity in 2011 (more). | We have deprioritized further work on this program based on our assessment of the evidence of effectiveness for the program. See our review of this program. | No further work planned | ||||||||||||||||||||||
73 | Micronutrient powders | Providing packets of vitamins and minerals to be added to children's food to reduce micronutrient deficiencies. | No | We have depriortized further work on this program based on our shallow assessment of the cost-effectiveness of the program. See our short note on this program. | No further work planned | ||||||||||||||||||||||
74 | Neonatal vitamin A supplementation (NVAS) | Administering a large dose of vitamin A to infants shortly after birth in order to reduce infant mortality. | No | We have deprioritized further work on this program based on our shallow assessment of the evidence for effectiveness and our impression that there is limited room for more funding. See our short note on this program. | No further work planned | ||||||||||||||||||||||
75 | Non-pneumatic anti-shock garments | Using a compression device to stabilize women with postpartum hemorrhage until they are able to receive treatment. | No | We have deprioritized further work on this program based on our shallow assessment of room for more funding. See our short note on this program. | No further work planned | ||||||||||||||||||||||
76 | Oral ivermectin mass drug administration for scabies control | Distributing the oral antiparasitic drug ivermectin to almost all members of a scabies-affected community with the intention of reducing the prevalence of scabies mites | No | We have deprioritized further work on this program based on our assessment of its cost-effectiveness and room for more funding. See our review of this program. | No further work planned | ||||||||||||||||||||||
77 | Oral Pre-exposure Prophylaxis (PrEP) for HIV | Providing antiretroviral drugs to HIV-negative individuals, in order to prevent HIV acquisition. (More) | No | We have deprioritized further work on this program based on our assessment of the cost-effectiveness of the program. See our review of this program. | No further work planned | ||||||||||||||||||||||
78 | Polio eradication activities | Providing support for polio vaccination in endemic countries and support activities and programs in non-endemic countries. | No | We have deprioritized further work on this program based on our shallow estimate of the cost-effectiveness of the program. See our short note on this program. | No further work planned | ||||||||||||||||||||||
79 | Post-discharge malaria chemoprevention (PDMC) for children with severe anemia | Providing antimalarials to children who have been treated in hospitals for severe anemia, after they have been discharged. | No | We have deprioritized further work on this program due to our impression that there are limited funding opportunities. See our short note on this program. | No further work planned | ||||||||||||||||||||||
80 | Precision Development (PxD) | Providing locally-customized agricultural advice to farmers through their mobile phones. (More) | This is not a program we are actively supporting. We recognized PxD as a GiveWell standout charity before GiveWell retired that designation (more) and made a scoping grant in March 2022 (more), a bridge grant in September 2022, and a core operations grant in March 2023 (more). | Our best guess is that this program is below the range of cost-effectiveness of programs we would consider directing funding to and evidence for its effectiveness is limited, though it's possible additional work could change our view. See our review of this program. | No further work planned | ||||||||||||||||||||||
81 | Probiotics for gestational diabetes | Providing probiotics to pregnant women with gestational diabetes to improve maternal and neonatal health. | No | We have deprioritized further work on this program based on our impression that there is limited evidence on its effectiveness. See our short note on this program. | No further work planned | ||||||||||||||||||||||
82 | Programs to increase the supply of midwives | Supporting the addition of midwives to areas with insufficient maternal and neonatal healthcare workers. | No | We have deprioritized further work on this program based on low estimated cost-effectiveness, lack of direct evidence for the program, and our uncertainty about whether there are specific giving opportunities in this space. See our short note on this program. | No further work planned | ||||||||||||||||||||||
83 | Prophylactic antibiotics to reduce infections from caesarean sections | Providing prophylactic antibiotics to women delivering via caesarean section to prevent morbidity and mortality related to maternal peripartum infections. | No | We have deprioritized further work on this program based on our impression that there will be limited funding opportunities. See our short note on this program. | No further work planned | ||||||||||||||||||||||
84 | Rapid diagnostic tests and drug therapy for visceral leishmaniasis in East Africa | Providing screening and treatment for a tropical disease that is prevalent in East Africa. | No | We have deprioritized further work based on limited room for more funding. See our short note on this program. | No further work planned | ||||||||||||||||||||||
85 | Safe birth kits for pregnant people | Providing safe birth kits to pregnant people to reduce the risk of neonatal or maternal mortality. | No | We have deprioritized further work on this program based on low estimated cost-effectiveness, though it's possible additional work could change our view. See our short note on this program. | No further work planned | ||||||||||||||||||||||
86 | School feeding programs | Providing school meals to students for the purpose of alleviating malnutrition, decreasing barriers to school attendance, and improving learning ability. | No | We have depriortized further work on this program based on our shallow assessment of the cost-effectiveness of the program. See our short note on this program. | No further work planned | ||||||||||||||||||||||
87 | Selenium supplementation for neonatal sepsis prevention | Providing selenium supplements to very low birthweight infants in order to prevent sepsis. | No | We have deprioritized further work on this program based on our impression that there is limited evidence on its effectiveness. See our short note on this program. | No further work planned | ||||||||||||||||||||||
88 | Small-quantity lipid nutrient supplementation | Distributing lipid-based nutrient supplements to children to prevent malnutrition. | No | We have deprioritized further work on this program based on low estimated cost-effectiveness. See our short note on this program. | No further work planned | ||||||||||||||||||||||
89 | Soft skills certification | Providing workers with certifications for non-cognitive skills, including traits such as trustworthiness and willingness to help others, in order to increase workers’ earnings by improving their ability to signal soft skills to potential employers. (More) | No | We have deprioritized further work on this program based on our assessment of the evidence of effectiveness for the program. See our review of this program. | No further work planned | ||||||||||||||||||||||
90 | StrongMinds | Group interpersonal psychotherapy (IPT-G) targeting women with depression. | No | We assessed Happier Lives Institute's cost-effectiveness analysis of StrongMinds. Our best guess is that StrongMinds is less cost-effective than other programs we'd consider directing funding to, though we think a wide range of cost-effectiveness is possible and additional research could change our view. | No further work planned | ||||||||||||||||||||||
91 | Supplementary immunization activities to prevent measles | Identifying gaps in measles vaccination coverage, including through vaccine coverage surveys or case surveillance, and conducting measles immunization campaigns in at-risk areas. (More) | No | We have deprioritized further work on this program based on our assessment of lack of cost-effective room for more funding for the program. See our review of this program. | No further work planned | ||||||||||||||||||||||
92 | Surgery to repair obstetric fistula | Providing surgery to repair abnormal openings between the vagina and the bladder or rectum that cause leakage of urine and/or feces. (More) | No | Our best guess is that surgery to treat obstetric fistula is below the range of cost-effectiveness of programs we would direct funding to. However, several major unanswered questions remain, and it is possible that new information on the benefits of fistula surgery or its costs could lead us to change our view. See our review of this program. | No further work planned | ||||||||||||||||||||||
93 | Targeted azithromycin distribution for children being discharged from the hospital | Providing a course of antibiotics at discharge from the hospital to children with recent severe illness, in order to reduce mortality and morbidity. | No | We have deprioritized further work on this program based on our impression that there is limited global room for more funding. See our short note on this program. | No further work planned | ||||||||||||||||||||||
94 | Unconditional cash transfers during pregnancy and when children are very young | Providing cash transfers targeted to women during pregnancy and when children are very young to provide a household income stream. | No | We have deprioritized further work on this program based on our shallow assessment of the cost-effectiveness of the program. See our short note on this program. | No further work planned | ||||||||||||||||||||||
95 | Universal low-dose aspirin during pregnancy | Distributing low-dose aspirin to all pregnant women to reduce the likelihood of preeclampsia. | No | We have deprioritized further work on this program based on our impression that there will be limited funding opportunities. See our short note on this program. | No further work planned | ||||||||||||||||||||||
96 | Voluntary medical male circumcision | Providing surgery to remove the prepuce (foreskin) of the penis, in order to reduce HIV and HPV (which can lead to cervical cancer) transmission. (More) | No | We have deprioritized further work on this program based on low estimated cost-effectiveness. See our review of this program. | No further work planned | ||||||||||||||||||||||
97 | Zusha! road safety campaign | Placing stickers in public service vehicles that encourage passengers to speak up and urge drivers to drive more safely. (More) | This is not a program we are actively supporting. We recommended a grant to Zusha! in 2017 (more). We recognized Zusha! as a GiveWell standout charity before GiveWell retired that designation (more). | We have deprioritized further work on this program based on our assessment of the cost-effectiveness of the program. See our review of this program. | No further work planned |